Douglas Hutchens
Director/Board Member chez ANIMALCARE GROUP PLC
Profil
Douglas Eugene Hutchens is an Independent Non-Executive Director at Animalcare Group Plc and the Chief Scientific Officer at Animol Discovery.
He was previously a Director at Crenae Therapeutics, Inc. and the Chief Veterinary Officer & Executive VP at Bayer Animal Health.
He also worked as an Assistant Professor at the University of Illinois College of Veterinary Medicine.
Hutchens holds a doctorate degree from the University of Illinois.
Postes actifs de Douglas Hutchens
| Sociétés | Poste | Début |
|---|---|---|
| ANIMALCARE GROUP PLC | Director/Board Member | 10/02/2022 |
Animol Discovery
 Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Douglas Hutchens
| Sociétés | Poste | Fin |
|---|---|---|
| Crenae Therapeutics, Inc. | Director/Board Member | 01/08/2022 |
Bayer Animal Health
 Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Corporate Officer/Principal | 01/07/2020 |
| University of Illinois College of Veterinary Medicine | Corporate Officer/Principal | - |
Formation de Douglas Hutchens
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANIMALCARE GROUP PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Health Technology |
Animol Discovery
Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Health Technology |
| Crenae Therapeutics, Inc. |
